High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy of a flexible high dose of lurasidone to a
standard dose of lurasidone in patients with treatment resistant schizophrenia or
schizoaffective disorder. Efficacy of both dosage groups will be measured through testing of
positive symptoms and other components of psychopathology (negative symptoms, general
psychopathology, anxiety, depression, cognitive function, global function, severity of
illness and tolerability). Patients must qualify for treatment resistance after two or more
antipsychotic drug trials to be included in this trial.